investorscraft@gmail.com

Intrinsic ValueJiang Su Yida Chemical Co.,Ltd (300721.SZ)

Previous Close$17.54
Intrinsic Value
Upside potential
Previous Close
$17.54

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Jiang Su Yida Chemical operates as a specialized chemical producer focused on manufacturing ethylene glycol ether and propylene glycol ether series, along with their derivatives, serving industrial markets primarily within China. The company's product portfolio extends to specialized offerings including ethyl glyme, propyl glyme, braking fluid, polyethylene glycol, and various polyether products, positioning it within the niche segment of high-purity solvent and functional fluid chemicals. This strategic focus on glycol ethers and derivatives caters to demanding applications in sectors such as coatings, inks, electronics, and pharmaceuticals, where product purity and consistent performance are critical. Founded in 1996 and headquartered in Jiangyin, a key chemical industry hub, the company has established a long-standing presence in the domestic market. Its market position is characterized by specialization in a specific chemical chain rather than broad commodity production, allowing it to cultivate technical expertise and customer relationships. The competitive landscape involves competing with other domestic specialty chemical producers on factors like product quality, technical service, and cost efficiency, within the context of China's large and evolving industrial base.

Revenue Profitability And Efficiency

For the fiscal year, the company reported revenue of approximately CNY 1.77 billion. Profitability was modest, with net income of CNY 9.53 million, resulting in a thin net margin. Operating cash flow generation was significantly stronger at CNY 217.8 million, indicating that cash conversion from operations remains healthy despite the pressure on bottom-line earnings, with capital expenditures of CNY 75.2 million reflecting ongoing investment in maintaining operations.

Earnings Power And Capital Efficiency

The company's diluted earnings per share stood at CNY 0.0578, reflecting its current modest earnings power. The substantial positive operating cash flow relative to net income suggests non-cash charges may be impacting reported profitability. The relationship between operating cash flow and capital expenditures indicates the company is generating sufficient cash from operations to fund its investment needs, a positive sign for fundamental capital efficiency.

Balance Sheet And Financial Health

The balance sheet shows a cash position of CNY 215.8 million against total debt of CNY 978.1 million, indicating a leveraged financial structure. The level of debt relative to the company's market capitalization and earnings power requires careful monitoring. The net debt position suggests financial flexibility may be constrained, and the company's health is dependent on stable operating cash flows to service its obligations.

Growth Trends And Dividend Policy

The company maintains a shareholder return policy, evidenced by a dividend per share of CNY 0.03. The payment of a dividend, even amid modest earnings, signals management's commitment to returning capital, though the sustainability of this policy is inherently linked to future profitability and cash flow generation. Growth trends appear challenged given the current low level of net income relative to the company's revenue base.

Valuation And Market Expectations

With a market capitalization of approximately CNY 2.35 billion, the market is valuing the company at a significant multiple of its current earnings, implying expectations of a substantial recovery in profitability or future growth. The beta of 0.139 suggests the stock has historically exhibited low volatility compared to the broader market, which may reflect its niche market positioning or specific investor base.

Strategic Advantages And Outlook

The company's primary strategic advantage lies in its long-established specialization within the glycol ethers market in China. The outlook is closely tied to demand cycles in its end-markets, such as coatings and electronics, and its ability to navigate raw material cost pressures. Success will depend on leveraging its technical expertise to maintain product quality and customer loyalty while improving operational efficiency to enhance profitability from its existing revenue base.

Sources

Company DescriptionFinancial Data Provided

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount